Skip to main content

Glaucoma clinical trials at UCSF
1 in progress, 1 open to new patients

  • Ahmed Glaucoma Valve Surgery With Mitomycin-C

    open to eligible people ages 18–85

    This study will determine the effectiveness of Mitomycin-C use in the glaucoma surgery Ahmed valve implantation. Approximately 100 patients will be enrolled, with half receiving the Mitomycin-C treatment and the other half receiving placebo treatment.

    San Francisco, California and other locations